Figure S5 from A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study Kazufumi Kobayashi , Sadahisa Ogasawara , Susumu Maruta , Tomomi Okubo , Norio Itokawa , Yuki Haga , Yuya Seko , Michihisa Moriguchi , Shunji Watanabe , Yuki Shiko , Hirokazu Takatsuka , Hiroaki Kanzaki , Keisuke Koroki , Masanori Inoue , Masato Nakamura , Soichiro Kiyono , Naoya Kanogawa , Takayuki Kondo , Eiichiro Suzuki , Yoshihiko Ooka , Shingo Nakamoto , Yosuke Inaba , Masafumi Ikeda , Shinichiro Okabe , Naoki Morimoto , Yoshito Itoh , Kazuyoshi Nakamura , Kenji Ito , Ryosaku Azemoto , Masanori Atsukawa , Ei Itobayashi , Naoya Kato crossref（2023）
摘要
Relationship between plasma concentration levels and lenvatinib dose modification
更多 查看译文
AI 理解论文
溯源树
样例
